keyword
https://read.qxmd.com/read/38636095/ethnicity-and-sudden-cardiac-death-in-athletes-insights-from-a-large-united-kingdom-registry
#1
JOURNAL ARTICLE
Gherardo Finocchiaro, Davide Radaelli, Stefano D'Errico, Raghav Bhatia, Michael Papadakis, Elijah R Behr, Joseph Westaby, Sanjay Sharma, Mary N Sheppard
BACKGROUND AND AIMS: The relationship between ethnicity and causes of sudden cardiac death (SCD) in athletes is poorly understood. OBJECTIVES: To investigate etiology of SCD among different ethnicities in a large cohort of athletes. METHODS: Between 1994 and November 2022, 7880 cases of SCD were consecutively referred from all over the United Kingdom to our national cardiac pathology centre; 848 (11%) were athletes. All cases underwent detailed autopsy evaluation by expert cardiac pathologists...
April 18, 2024: European Journal of Preventive Cardiology
https://read.qxmd.com/read/38636093/accurate-prediction-equations-for-ventilatory-thresholds-in-cardiometabolic-disease-when-gas-exchange-analysis-is-unavailable-development-and-validation
#2
JOURNAL ARTICLE
Juliana Goulart Prata Oliveira Milani, Mauricio Milani, Felipe Vilaça Cavallari Machado, Matthias Wilhelm, Thimo Marcin, Flavio D'Ascenzi, Luna Cavigli, Charly Keytsman, Maarten Falter, Bruno Bonnechere, Raf Meesen, Fabrício Braga, Graziella França Bernardelli Cipriano, Veronique Cornelissen, Kenneth Verboven, Gerson Cipriano Junior, Dominique Hansen
AIMS: To develop and validate equations predicting heart rate (HR) at the first and second ventilatory thresholds (VTs) and an optimized range-adjusted prescription for patients with cardiometabolic disease (CMD). To compare their performance against guideline-based exercise intensity domains. METHODS: Cross-sectional study involving 2,868 CMD patients from nine countries. HR predictive equations for first and second VTs (VT1, VT2) were developed using multivariate linear regression with 975 cycle-ergometer cardiopulmonary exercise tests (CPET)...
April 18, 2024: European Journal of Preventive Cardiology
https://read.qxmd.com/read/38636089/in-reply
#3
JOURNAL ARTICLE
Edward John Pavlik, Anne Lasher, Lauren E Harris, Angelica L Solomon, Laura M Harbin, Lauren Raby, Charles S Dietrich, Richard J Kryscio, John R van Nagell
No abstract text is available yet for this article.
May 1, 2024: Obstetrics and Gynecology
https://read.qxmd.com/read/38635936/methodology-for-using-real-world-data-from-electronic-health-records-to-assess-chemotherapy-administration-in-women-with-breast-cancer
#4
JOURNAL ARTICLE
Jenna Bhimani, Kelli O'Connell, Isaac J Ergas, Marilyn Foley, Grace B Gallagher, Jennifer J Griggs, Narre Heon, Tatjana Kolevska, Yuriy Kotsurovskyy, Candyce H Kroenke, Cecile A Laurent, Raymond Liu, Kanichi G Nakata, Sonia Persaud, Donna R Rivera, Janise M Roh, Sara Tabatabai, Emily Valice, Erin J A Bowles, Elisa V Bandera, Lawrence H Kushi, Elizabeth D Kantor
PURPOSE: Identification of patients' intended chemotherapy regimens is critical to most research questions conducted in the real-world setting of cancer care. Yet, these data are not routinely available in electronic health records (EHRs) at the specificity required to address these questions. We developed a methodology to identify patients' intended regimens from EHR data in the Optimal Breast Cancer Chemotherapy Dosing (OBCD) study. METHODS: In women older than 18 years, diagnosed with primary stage I-IIIA breast cancer at Kaiser Permanente Northern California (2006-2019), we categorized participants into 24 drug combinations described in National Comprehensive Cancer Network guidelines for breast cancer treatment...
April 2024: JCO Clinical Cancer Informatics
https://read.qxmd.com/read/38635921/high-efficiency-rechargeable-fe-co-2-battery-a-route-for-effective-co-2-conversion-and-energy-storage
#5
JOURNAL ARTICLE
Anil D Pathak, Pashupati R Adhikari, Wonbong Choi
Because of their high theoretical energy density, metal-CO2 batteries based on Li, Na, or K have attracted increasing attention recently for meeting the growing demands of CO2 recycling and conversion into electrical energy. However, the scarcity of active anode material resources, high cost, as well as safety concerns of Li, Na, and K create obstacles for practical applications. Herein, we demonstrate for the first time a high-efficiency (η = 77.2%) rechargeable Fe-CO2 battery that is composed of iron (Fe) anode and MoS2 -catalysts deposited carbon cathode...
April 18, 2024: ACS Applied Materials & Interfaces
https://read.qxmd.com/read/38635906/plantar-pressure-analysis-of-different-orthoses-in-patients-after-first-metatarsophalangeal-joint-arthrodesis
#6
JOURNAL ARTICLE
Dana Golden, R O Corbett, Minton Truitt Cooper, Jay Hertel
BACKGROUND: There is no gold standard for a walking orthosis after first metatarsophalangeal joint (MTPJ) arthrodesis surgery. Evaluation of plantar pressure measures and patient perceptions for different orthoses may assist surgeons to choose a postsurgery orthotic. The purpose of this study was to measure plantar pressure under the distal first ray during walking and patient perceptions of comfort, stability, and preference with 4 different orthoses in patients with a history of first MTPJ arthrodesis...
April 18, 2024: Prosthetics and Orthotics International
https://read.qxmd.com/read/38635903/cd58-alterations-govern-antitumor-immune-responses-by-inducing-pd-l1-and-ido-in-diffuse-large-b-cell-lymphoma
#7
JOURNAL ARTICLE
Xiyue Xu, Yidan Zhang, Yaxiao Lu, Xiaoyan Zhang, Cuicui Zhao, Jiesong Wang, Qingpei Guan, Yingfang Feng, Meng Gao, Jingwei Yu, Zheng Song, Xia Liu, Zahra Golchehre, Lanfang Li, Weicheng Ren, Qiang Pan-Hammarström, Huilai Zhang, Xianhuo Wang
Recurrent abnormalities in immune surveillance-related genes affect the progression of diffuse large B-cell lymphoma (DLBCL) and modulate the response to therapeutic interventions. CD58 interacts with the CD2 receptor on T cells and natural killer (NK) cells and is recurrently mutated and deleted in DLBCL, suggesting it may play a role in regulating antitumor immunity. Herein, we comprehensively analyzed the genomic characteristics of CD58 through targeted next-generation sequencing, RNA-sequencing, whole-exome sequencing, and single-cell RNA-sequencing in patients with newly diagnosed DLBCL...
April 18, 2024: Cancer Research
https://read.qxmd.com/read/38635895/fc-silent-anti-tigit-antibodies-potentiate-anti-tumor-immunity-without-depleting-regulatory-t-cells
#8
JOURNAL ARTICLE
Dana Piovesan, Amber E de Groot, Soonweng Cho, Amy E Anderson, Rebecca D Ray, Amita Patnaik, Paul G Foster, Casey G Mitchell, Alejandra Y Lopez Espinoza, Wandi S Zhu, Carlo E Stagnaro, Hema Singh, Xiaoning Zhao, Lisa Seitz, Nigel P Walker, Matthew J Walters, Kelsey E Sivick
TIGIT is an inhibitory receptor on immune cells that outcompetes an activating receptor, CD226, for shared ligands. Tumor-infiltrating lymphocytes express TIGIT and CD226 on regulatory T cells (Treg) and on CD8+ T cells with tumor-reactive or exhausted phenotypes, supporting the potential of therapeutically targeting TIGIT to enhance anti-tumor immunity. To optimize the efficacy of therapeutic antibodies against TIGIT, it is necessary to understand whether there is therapeutic benefit from Fcγ receptor (FcγR) binding...
April 18, 2024: Cancer Research
https://read.qxmd.com/read/38635867/rift-valley-fever-virus-encephalitis-viral-and-host-determinants-of-pathogenesis
#9
REVIEW
Lindsay R Wilson, Anita K McElroy
Rift Valley fever virus (RVFV) is a mosquito-borne virus endemic to Africa and the Middle East. RVFV infection can cause encephalitis, which is associated with significant morbidity and mortality. Studies of RVFV encephalitis following percutaneous inoculation, as would occur following a mosquito bite, have historically been limited by a lack of consistent animal models. In this review, we describe new insights into the pathogenesis of RVFV and the opportunities provided by new mouse models. We underscore the need to consider viral strain and route of inoculation when interpreting data obtained using animal models...
April 18, 2024: Annual Review of Virology
https://read.qxmd.com/read/38635862/structural-lung-disease-and-clinical-phenotype-in-bronchiectasis-patients-the-embarc-ct-study
#10
JOURNAL ARTICLE
Angelina L P Pieters, Tjeerd van der Veer, Jennifer J Meerburg, Eleni-Rosalina Andrinopoulou, Menno M Vd Eerden, Pierluigi Ciet, Stefano Aliberti, Pierre-Regis Burgel, Megan L Crichton, Amelia Shoemark, Pieter C Goeminne, Michal Shteinberg, Michael R Loebinger, Charles S Haworth, Francesco Blasi, Harm Awm Tiddens, Daan Caudri, James D Chalmers
RATIONALE: Chest computed tomography -scans (CTs) are essential to diagnose and monitor bronchiectasis (BE). To date, little quantitative data is available about the nature and extent of structural lung abnormalities (SLA) on CTs of BE patients. OBJECTIVES: to investigate SLA on CTs of patients with bronchiectasis and the relationship of SLAs to clinical features using the European Bronchiectasis Registry (EMBARC) Methods: CTs from BE patients included in the EMBARC registry were analyzed using the validated Bronchiectasis Scoring Technique for CT (BEST-CT)...
April 18, 2024: American Journal of Respiratory and Critical Care Medicine
https://read.qxmd.com/read/38635856/non-invasive-assessment-of-stroke-volume-and-cardiovascular-parameters-based-on-peripheral-pressure-waveform
#11
JOURNAL ARTICLE
Kamil Wołos, Leszek Pstras, Malgorzata Debowska, Wojciech Dabrowski, Dorota Siwicka-Gieroba, Jan Poleszczuk
Cardiovascular diseases are the leading cause of death globally, making the development of non-invasive and simple-to-use tools that bring insights into the state of the cardiovascular system of utmost importance. We investigated the possibility of using peripheral pulse wave recordings to estimate stroke volume (SV) and subject-specific parameters describing the selected properties of the cardiovascular system. Peripheral pressure waveforms were recorded in the radial artery using applanation tonometry (SphygmoCor) in 35 hemodialysis (HD) patients and 14 healthy subjects...
April 18, 2024: PLoS Computational Biology
https://read.qxmd.com/read/38635839/comorbidities-affecting-re-admission-and-survival-in-covid-19-application-of-joint-frailty-model
#12
JOURNAL ARTICLE
Akram Yazdani, Seyyed Ali Mozaffarpur, Pouyan Ebrahimi, Hoda Shirafkan, Hamed Mehdinejad
BACKGROUND: One of the common concerns of healthcare systems is the potential for re-admission of COVID-19 patients. In addition to adding costs to the healthcare system, re-admissions also endanger patient safety. Recognizing the factors that influence re-admission, can help provide appropriate and optimal health care. The aim of this study was to assess comorbidities that affect re-admission and survival in COVID-19 patients using a joint frailty model. METHODS: This historical cohort study was done using data of patients with COVID-19 who were re-hospitalized more than twice in a referral hospital in North of Iran...
2024: PloS One
https://read.qxmd.com/read/38635836/ranking-of-cell-clusters-in-a-single-cell-rna-sequencing-analysis-framework-using-prior-knowledge
#13
JOURNAL ARTICLE
Anastasis Oulas, Kyriaki Savva, Nestoras Karathanasis, George M Spyrou
Prioritization or ranking of different cell types in a Single-cell RNA Sequencing (scRNA-Seq) framework can be performed in a variety of ways, some of these include: i) obtaining an indication of the proportion of cell types between the different conditions under study, ii) counting the number of differentially expressed genes (DEGs) between cell types and conditions in the experiment or, iii) prioritizing cell types based on prior knowledge about the conditions under study (i.e., a specific disease). These methods have drawbacks and limitations thus novel methods for improving cell ranking are required...
April 18, 2024: PLoS Computational Biology
https://read.qxmd.com/read/38635788/human-herpesvirus-6-reactivation-and-disease-are-infrequent-in-chimeric-antigen-receptor-t-cell-therapy-recipients
#14
JOURNAL ARTICLE
Eleftheria Kampouri, Elizabeth M Krantz, Hu Xie, Sarah S Ibrahimi, Erika S Kiem, Mandeep K Sekhon, Emily C Liang, Andrew J Cowan, Andrew J Portuguese, Damian J Green, Aya Albittar, Jennifer J Huang, Jordan Gauthier, Ailyn C Pérez-Osorio, Keith R Jerome, Danielle Zerr, Michael J Boeckh, Joshua A Hill
Human herpesvirus-6B (HHV-6B) reactivation and disease are increasingly reported after CAR-T-cell therapy (CARTx). HHV-6 reactivation in the CAR-T-cell product was recently reported, raising questions about product and patient management. Due to overlapping manifestations with immune effector cell-associated neurotoxicity syndrome, diagnosing HHV-6B encephalitis is challenging. We provide two lines of evidence assessing the incidence and outcomes of HHV-6B after CARTx. First, in a prospective study with weekly HHV-6B testing for up to 12 weeks post-infusion, HHV-6B reactivation occurred in eight of 89 participants; three had chromosomally integrated HHV-6 and were excluded, resulting in a cumulative incidence of HHV-6B reactivation of 6% (95% confidence interval (CI), 2...
April 18, 2024: Blood
https://read.qxmd.com/read/38635771/remote-olfactory-assessment-using-the-nih-toolbox-odor-identification-test-and-the-brain-health-registry
#15
JOURNAL ARTICLE
Cristina Jaén, Christopher Maute, Scott Mackin, Monica R Camacho, Diana Truran, Rachel Nosheny, Michael W Weiner, Pamela Dalton
BACKGROUND: Early identification of deficits in our ability to perceive odors is important as many normal (i.e., aging) and pathological (i.e., sinusitis, viral, neurodegeneration) processes can result in diminished olfactory function. To realistically enable population-level measurements of olfaction, validated olfaction tests must be capable of being administered outside the research laboratory and clinical setting. AIM: The purpose of this study was to determine the feasibility of remotely testing olfactory performance using a test that was developed with funding from the National Institutes of Health as part of a ready-to-use, non-proprietary set of measurements useful for epidemiologic studies (NIH Toolbox Odor ID Test)...
2024: PloS One
https://read.qxmd.com/read/38635767/deep-phenotyping-of-dementia-in-a-multi-ethnic-cardiovascular-cohort-the-multi-ethnic-study-of-atherosclerosis-mesa
#16
JOURNAL ARTICLE
Mohammad R Ostovaneh, Timothy M Hughes, Colin O Wu, Robyn L McClelland, Ramon Casanova, David A Bluemke, Russell P Tracy, Steven Shea, Susan R Heckbert, João A C Lima, Bharath Ambale-Venkatesh
BACKGROUND: Our understanding of the specific aspects of vascular contributions to dementia remains unclear. OBJECTIVES: We aim to identify the correlates of incident dementia in a multi-ethnic cardiovascular cohort. METHODS: A total of 6806 participants with follow-up data for incident dementia were included. Probable dementia diagnoses were identified using hospitalization discharge diagnoses according to the International Classification of Diseases Codes (ICD)...
2024: PloS One
https://read.qxmd.com/read/38635762/real-world-and-clinical-trial-outcomes-in-large-b-cell-lymphoma-with-axicabtagene-ciloleucel-across-race-and-ethnicity
#17
JOURNAL ARTICLE
Frederick L Locke, Tanya Siddiqi, Caron A Jacobson, Armin Ghobadi, Sairah Ahmed, David B Miklos, Miguel-Angel Perales, Javier Munoz, Warren B Fingrut, Martina Pennisi, Jordan Gauthier, Mazyar Shadman, Lohith Gowda, Abu-Sayeef Mirza, Muhammad Bilal Abid, Sanghee Hong, Navneet S Majhail, Mohamed A Kharfan-Dabaja, Arushi Khurana, Talha Badar, Yi Lin, N Nora Bennani, Megan M Herr, Zhen-Huan Hu, Hailin Wang, Anjani Baer, Elande Baro, Harry Miao, Clare Spooner, Hairong Xu, Marcelo C Pasquini
Axicabtagene ciloleucel (axi-cel) is an autologous anti-CD19 chimeric antigen receptor (CAR) T-cell therapy approved for treatment of relapsed/refractory (R/R) large B-cell lymphoma (LBCL). Despite extensive data supporting the use of axi-cel in patients with LBCL, outcomes stratified by race and ethnicity groups are limited. Here, we report clinical outcomes with axi-cel in patients with R/R LBCL by race and ethnicity in both real-world and clinical trial settings. In the real-world setting, 1290 patients with R/R LBCL who received axi-cel between 2017-2020 were identified from the Center for International Blood and Marrow Transplant Research database; 106 and 169 patients were included from the ZUMA-1 and ZUMA-7 clinical trials, respectively...
April 18, 2024: Blood
https://read.qxmd.com/read/38635742/electron-plasma-diagnostics-in-eltrap-by-electron-cyclotron-resonance-heating-method
#18
JOURNAL ARTICLE
Faisal Khan, Muhammad Ikram, Mostafa Rashdan, Fahmi Elsayed, Pervaiz Ahmad, Mayeen Uddin Khandaker
Electron cyclotron resonance heating method of Particle-in-Cell code was used to analyze heating phenomena, axial kinetic energy, and self-consistent electric field of confined electron plasma in ELTRAP device by hydrogen and helium background gases. The electromagnetic simulations were performed at a constant power of 3.8 V for different RF drives (0.5 GHz- 8 GHz), as well as for 1 GHz constant frequency at these varying amplitudes (1 V-3.8 V). The impacts of axial and radial temperatures were found maximum at 1...
2024: PloS One
https://read.qxmd.com/read/38635738/eacvi-survey-on-radiation-exposure-in-interventional-echocardiography
#19
JOURNAL ARTICLE
E Galli, H Soliman-Aboumarie, L Gargani, P Szymański, A Gimelli, S E Petersen, L E Sade, I Stankovic, E Donal, B Cosyns, E Agricola, M R Dweck, N Ajmone Marsan, V Delgado, D Muraru
AIMS: The European Association of Cardiovascular Imaging (EACVI) Scientific Initiatives Committee performed a global survey on radiation exposure in interventional echocardiography. The survey aimed to collect data on local practices for radioprotection in interventional echocardiography and to assess the awareness of echocardiography operators about radiation-related risks. METHODS AND RESULTS: A total of 258 interventional echocardiographers from 52 different countries (48% European) responded to the survey...
April 18, 2024: European Heart Journal Cardiovascular Imaging
https://read.qxmd.com/read/38635729/activated-rate-response-is-associated-with-increased-mortality-risk-in-cardiac-device-carriers-with-acute-heart-failure
#20
JOURNAL ARTICLE
Moritz T Huttelmaier, Sascha Münsterer, Caroline Morbach, Floran Sahiti, Nina Scholz, Judith Albert, Alexander Gabel, Christiane Angermann, Georg Ertl, Stefan Frantz, Stefan Störk, Thomas H Fischer
AIMS: This study investigated whether an activated R-mode in patients carrying a cardiac implantable electronic device (CIED) is associated with worse prognosis during and after an episode of acutely decompensated heart failure (AHF). METHODS: Six hundred and twenty-three patients participating in an ongoing prospective cohort study that phenotypes and follows patients admitted for AHF were studied. We compared CIED carriers with activated R-mode stimulation (CIED-R) to CIED carriers not in R-mode (CIED-0) and patients without CIEDs (no-CIED)...
2024: PloS One
keyword
keyword
28450
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.